Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day
June 16, 2022 09:44 ET
|
Genetron Holdings Limited
BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Receives CAP Accreditation for its Maryland Laboratory
June 15, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, June 15, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reports Unaudited First Quarter 2022 Financial Results
June 02, 2022 07:20 ET
|
Genetron Holdings Limited
BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, June 02, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes
June 01, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, June 01, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022
May 23, 2022 16:05 ET
|
Genetron Holdings Limited
BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®
April 19, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022
April 08, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, April 08, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments
April 07, 2022 06:00 ET
|
Genetron Holdings Limited
BEIJING, April 07, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022 07:26 ET
|
Genetron Holdings Limited
BEIJING, March 29, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...